ROSG August 17th Options Begin Trading

Investors in Rosetta Genomics Ltd ( ROSG) saw new options become available today, for the August 17th expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the ROSG options chain for the new August 17th contracts and identified one put and one call contract of particular interest.

The put contract at the $2.50 strike price has a current bid of 15 cents. If an investor was to sell-to-open that put contract, they are committing to purchase the stock at $2.50, but will also collect the premium, putting the cost basis of the shares at $2.35 (before broker commissions). To an investor already interested in purchasing shares of ROSG, that could represent an attractive alternative to paying $3.37/share today.

Because the $2.50 strike represents an approximate 26% discount to the current trading price of the stock (in other words it is out-of-the-money by that percentage), there is also the possibility that the put contract would expire worthless. The current analytical data (including greeks and implied greeks) suggest the current odds of that happening are 82%. Stock Options Channel will track those odds over time to see how they change, publishing a chart of those numbers on our website under the contract detail page for this contract. Should the contract expire worthless, the premium would represent a 6.00% return on the cash commitment, or 40.56% annualized — at Stock Options Channel we call this the YieldBoost.

Top YieldBoost Puts of the S&P 500 »

Below is a chart showing the trailing twelve month trading history for Rosetta Genomics Ltd, and highlighting in green where the $2.50 strike is located relative to that history:

If you liked this article you might like

Rosetta Genomics (ROSG) Stock Closed Up on Cantor Fitzgerald Rating

4 Biotech Stocks Under $10 Poised for Big Breakouts

Rosseta Genomics (ROSG) Stock Continues To Climb Today on Analyst Upgrade

Rosetta Genomics (ROSG) Stock is Spiking on Receipt of Cancer Origin Test Patent

Rosetta Genomics (ROSG) Stock Sells Off Today Following Tuesday's Surge